Tuberculosis caused by XDR resistant Mycobacterium tuberculosis in Poland. Microbiological and molecular analysis;Gruźlica wywotana pra̧tkami o opornosci XDR w Polsce. Badania mikrobiologiczne i molekularne

Pneumonologia i Alergologia Polska

Volumn 75, Issue 1, 2007, Pages 32-39

  Augustynowicz Kopeć, Ewa ^a   Zwolska, Zofia ^a  

^a INSTYTUT GRU LICY I CHORÓB P UC   (Poland)

Author keywords

MDR; Poland; Resistant tubercle bacilli; Spoligotyping; Tuberculosis; XDR

Indexed keywords

CAPREOMYCIN; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ARTICLE; CLASSIFICATION; DNA FINGERPRINTING; DRUG EFFECT; EPIDEMIOLOGY; GENETICS; HEALTH SURVEY; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; POLAND; PREVALENCE; RETROSPECTIVE STUDY; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CAPREOMYCIN SULFATE; DNA FINGERPRINTING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; ETHAMBUTOL; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; POLAND; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES; RIFAMPIN; STREPTOMYCIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 34347343864     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. WHO Global Programme on AIDS and tuberculosis programme in collaboration with the International Union Against Tuberculosis and Lung Disease. Statement on AIDS and tuberculosis. Geneva: WHO Organization, 1989. Bull Int. Union Tuberc. Lung. Dis. 1989; 64: 8-11.
2. Pearson M.L., Jereb J.A., Frieden T.R. i wsp. Nosocomial transmission of multi-resistant Mycobacterium tuberculosis a risk to patients and health care workers. Ann. Inter. Med. 1992; 117: 191-196.
3. Gandhi N.R., Moll A., Sturm A.W. i wsp. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575-1580.
4. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2002-2004. Morb, Mortal Wkly. Rep. 2006; 55: 301-305.
5. Masjedi M.R., Farina P., Sorooch S. i wsp. Extensively Drug-resistant Tuberculosis: 2 year of surveillance in Iran. Clin. Infect. Dis. 2006; 43: 841-847.
6. Anon. The tuberculosis X factor. BMJ 2006; 333: 705.
7. Anti-tuberculosis drug resistance In the world. The WHO/ /IUATLD Global project on Anti-tuberculosis drug surveillance 1994-1997. Report 2. WHO, Geneva 2000.
8. Anti-tuberculosis drug resistance in the world. The WHO/ /IUATLD Global project on Anti-tuberculosis drug surveillance 1999-2002. Report 3. WHO, Geneva 2004.
9. Augustynowicz-Kopecl E., Zwolska Z., Jaworski A. i wsp. Czȩstość wystcpowanla gruźlicy lekoopornej w Polsce w 2000 r. w poro̧wnaniu z 1997 r. Pneumonol. Alergol. Pol. 2002; 70: 193-202.
10. Surveillance of tuberculosis in Europe-Euro TB. Report on tuberculosis cases notified in 2004. WHO Collaborating Centre for the Surveillance of Tuberculosis in Europe. EuroTB - Institut de Veille Sanitaire.
11. Zwolska Z., Augustynowicz-Kopeć E., Klatt M. Pierwotna 1 nabyta lekoopornosć pra̧tków gruźlicy w Polsce. Pneumonol. Alergol. Pol. 1999; 67: 536-545.
12. Zwolska Z., Augustynowicz-Kopeć E., Klatt M. Wykorzystanie zdolności redukcyjnych pra̧tków kwasoopornych do szybkiego wykiywania ich wzrostu w hodowlach. Pneumonol, Alergol. Pol. 1998; 66: 38-44.
13. Augustynowlcz-Kopeć E., Jaglelski T., Kozihska M. i wsp. Znaczenle metody spollgotyping w epldemiologicznych dochodzeniach gruzlicy. Pneumonol. Alergol. Pol. 2007; 75: 22-31.
14. Augustynowicz-Kopeć E., Kostrzewa E., Zwolska Z. Zastosowanle Etestu do określania lekowrazllwości Mycobacterium. Porównanle wyników z Innymi metodami, Pneumonol. Alergol. Pol. 2001; 69; 356.
15. Micdzynarodowa baza SpolDB4 (www.pasteur-guadeloupe.fi//tb/spoldb4).
16. Michałowska-Mitczuk D. Ocena przyczyn przewleklego wydalania pra̧tków przez chorych na gruźlicȩ płue i możliwości ich odprqtkowania. Praca doktorska. IGiCHP 1996.
17. Sajduda A., Dziadek J., Kotlowski R. i wsp. Evaluation of multiple genetic markers for typing drug-resistant Mycobacterium tuberculosis strains from Poland. Diagn. Microbiol. Infect. Dis. 2006; 55:59-64.